In an interview that took place at the European Society for Medical Oncology 2024 Congress in Barcelona, Spain, Timothy Yap, MBBS, PhD, medical oncologist, The University of Texas…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
By Andrew M. Seaman New York (Reuters Health) – Women with lung cancer who ate the most soy before their diagnosis might live a little longer than those…
An estimated 20 to 40 percent of cancer patients receiving certain types of chemotherapy treatments may experience debilitating pain. The pain can cause a number of symptoms including…
NEW YORK (Reuters Health) – Environmental factors appear to influence the incidence of papillary thyroid microcarcinomas (PTMCs), according to a comparison of epidemiologic data from Sicily and the…
NEW YORK (Reuters Health) – In a randomized controlled trial, the anti-CA-125 vaccine abagovomab did not prolong survival in patients with ovarian cancer in first remission — despite…
NEW YORK (Reuters Health) – Even without conventional conditioning and cytoxic chemotherapy, an allogeneic hematopoietic cell transplant (HCT) can have a substantial benefit in patients with advanced hematologic…
NEW YORK (Reuters Health) – Intraperitoneal chemotherapy may significantly improve long-term survival in ovarian cancer patients, a new study found. Data from 876 patients followed for a median…
NEW YORK (Reuters Health) – The risk of arterial thromboembollic events related to bevacizumab treatment of colorectal cancer (CRC) in older patients is moderate in general practice, and…
NEW YORK (Reuters Health) – In cancer patients with a central venous catheter (CVC), the occurrence of a related infection or thrombosis can often be resolved while the…
NEW YORK (Reuters Health) – The rate of incidental thyroid cancer detected among patients who undergo thyroidectomy for apparently benign disease is unexpectedly high, especially in cases of…
NEW YORK (Reuters Health) – Patients with acute myeloid leukemia (AML) who do not receive a stem-cell transplant during first remission and then relapse have a fair chance of…
